Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'
Tweet Send to a Friend
(Updated - June 17, 2026 7:43 AM EDT)
RBC Capital analyst Leonid Timashev raised the price target on Edgewise ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Leonid Timashev raised the price target on Edgewise ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
